- Report
- June 2025
- 400 Pages
Global
From €4376EUR$4,949USD£3,778GBP
- Newsletter
- August 2025
- 88 Pages
Global
€1165EUR$1,318USD£1,006GBP
- Report
- August 2022
- 214 Pages
Global
From €4243EUR$4,799USD£3,663GBP
- Report
- June 2023
- 186 Pages
Global
From €4111EUR$4,650USD£3,549GBP
- Report
- March 2023
- 150 Pages
Global
From €5261EUR$5,950USD£4,542GBP
- Report
- May 2024
- 133 Pages
Global
From €5746EUR$6,499USD£4,961GBP
- Report
- January 2024
- 94 Pages
United States
From €5261EUR$5,950USD£4,542GBP
- Report
- September 2023
- 190 Pages
Global
From €2202EUR$2,490USD£1,901GBP
- Report
- January 2024
- 257 Pages
Global
From €4421EUR$5,000USD£3,817GBP
- Report
- February 2024
- 110 Pages
Global
From €4200EUR$4,750USD£3,626GBP
- Report
- January 2024
- 200 Pages
Global
From €3669EUR$4,150USD£3,168GBP
- Report
- August 2024
- 265 Pages
Global
From €7029EUR$7,950USD£6,068GBP
- Report
- August 2024
- 185 Pages
Global
From €3979EUR$4,500USD£3,435GBP
- Report
- June 2024
- 200 Pages
Global
From €7029EUR$7,950USD£6,068GBP
- Report
- June 2024
- 200 Pages
Global
From €7029EUR$7,950USD£6,068GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4377EUR$4,950USD£3,778GBP
- Report
- January 2022
- 60 Pages
Global
From €3492EUR$3,950USD£3,015GBP
- Report
- April 2023
- 110 Pages
Global
From €4200EUR$4,750USD£3,626GBP
- Report
- April 2023
- 120 Pages
Global
From €4200EUR$4,750USD£3,626GBP
- Report
- May 2023
- 171 Pages
Global
From €2210EUR$2,500USD£1,908GBP
Bladder cancer is a type of cancer that affects the urinary bladder. It is the sixth most common type of cancer in the United States and the fourth most common type of cancer in Europe. Symptoms of bladder cancer include blood in the urine, pain during urination, and frequent urination. Treatment options for bladder cancer include surgery, chemotherapy, radiation therapy, and immunotherapy.
The oncology market for bladder cancer is highly competitive, with a range of treatments available. Pharmaceutical companies are developing new treatments to improve outcomes for patients, such as targeted therapies and immunotherapies. Additionally, research is being conducted to better understand the biology of bladder cancer and to develop new diagnostic tests.
Companies in the bladder cancer market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more
